Myxredlin™ (insulin human in sodium chloride) – New drug approval
June 20, 2019 - The FDA approved Celerity Pharmaceuticals’ Myxredlin (insulin human in sodium chloride), to improve glycemic control in adults and pediatric patients with diabetes mellitus.
Download PDF
